Stock SANA SANA BIOTECHNOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Sana Biotechnology, Inc.

Equities

SANA

US7995661045

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
7.56 USD +0.80% Intraday chart for Sana Biotechnology, Inc. -27.59% +85.29%
May. 08 Sana Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 18 Sana Biotechnology, Inc. Announces Resignation of Douglas Williams as Executive Vice President and President, Research and Development CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sana: Q1 Earnings Snapshot
AQ
Sana Biotechnology Reports First Quarter 2024 Financial Results and Business Updates
GL
Sana Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Sana Biotechnology to Present at May and June 2024 Investor Conferences
GL
Sana Biotechnology, Inc. Announces Resignation of Douglas Williams as Executive Vice President and President, Research and Development
CI
Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences
AQ
Certain Restricted Stock Units of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 9-APR-2024.
CI
Certain Stock Options of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 9-APR-2024.
CI
Certain Common Stock of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 9-APR-2024.
CI
JMP Securities Adjusts Sana Biotechnology Price Target to $15 From $8, Maintains Market Outperform Rating
MT
Sana Biotechnology Shares Rise as Q4 Non-GAAP Net Loss Narrows
MT
Sector Update: Health Care Stocks Edge Higher Premarket Friday
MT
Sana Biotechnology Q4 Non-GAAP Net Loss Narrows; Cash, Cash Equivalents Decline
MT
Sana: Q4 Earnings Snapshot
AQ
Sana Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Sana Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
GL
Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference
GL
Viridian Therapeutics Names Jennifer Tousignant as Chief Legal Officer
MT
Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SANA Stock
  4. News Sana Biotechnology, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW